Japan has implemented a rigorous surveillance program relying on regular US surveillance with AFP and two additional biomarkers, lectin-reactive α-fetoprotein (AFP-L3) and DCP, which results in improvement of overall survival of HCC patients [52,53]. Here, AFP is linked to hepatocellular carcinoma.